These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 16583545)
1. [Drug development costs are overstated by the industry]. Jeppsson A Lakartidningen; 2006 Mar 1-7; 103(9):663-4; discussion 664. PubMed ID: 16583545 [No Abstract] [Full Text] [Related]
2. Pharmaceutical research: cost savings through innovation. Cohen KR; Levy RA AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463 [No Abstract] [Full Text] [Related]
3. Drug costs: research and development costs: the great illusion. Prescrire Int; 2004 Feb; 13(69):32-6. PubMed ID: 15055226 [TBL] [Abstract][Full Text] [Related]
4. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy? Ferris LE CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844 [No Abstract] [Full Text] [Related]
5. [The roles and responsibilities of the pharmaceutical industry]. Dejgaard A; Thomsen MK Ugeskr Laeger; 2003 Apr; 165(16):1676-9. PubMed ID: 12756829 [TBL] [Abstract][Full Text] [Related]
6. The state of innovation in drug development. Kola I Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690 [TBL] [Abstract][Full Text] [Related]
7. The price of pills. Does it really take $897 million for a new therapy? Ezzell C Sci Am; 2003 Jul; 289(1):25. PubMed ID: 12840941 [No Abstract] [Full Text] [Related]
8. Two ideas to increase innovation and reduce pharmaceutical costs and prices. Jayadev A; Stiglitz J Health Aff (Millwood); 2009; 28(1):w165-8. PubMed ID: 19088104 [TBL] [Abstract][Full Text] [Related]
9. [Is society going to finance projects of drug companies?]. Bake B Lakartidningen; 1999 May; 96(19):2327-8. PubMed ID: 10377674 [No Abstract] [Full Text] [Related]
10. [Current challenges for the pharmaceutical research industry]. Chalchat B Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118 [TBL] [Abstract][Full Text] [Related]
11. The pharmaceutical industry--to whom is it accountable? Hayes TA N Engl J Med; 2000 Nov; 343(19):1416; discussion 1417. PubMed ID: 11183881 [No Abstract] [Full Text] [Related]
12. Fewer new drugs from the pharmaceutical industry. Taylor D BMJ; 2003 Feb; 326(7386):408-9. PubMed ID: 12595352 [No Abstract] [Full Text] [Related]
13. Industry sponsored bias in cost effectiveness analyses. John-Baptiste A; Bell C BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724 [No Abstract] [Full Text] [Related]
14. Costing drug development. Nat Rev Drug Discov; 2003 Apr; 2(4):247. PubMed ID: 12680358 [No Abstract] [Full Text] [Related]
15. Drug price deal spells windfall for researchers. Bosch X Nature; 2001 Nov; 414(6860):138. PubMed ID: 11700514 [No Abstract] [Full Text] [Related]
16. Victoria, a springboard for a research based pharmaceutical industry. Windle HK Australas Biotechnol; 1991 Oct; 1(2):88-91. PubMed ID: 1367647 [No Abstract] [Full Text] [Related]
17. Cutting the cost of drug development? Rawlins MD Nat Rev Drug Discov; 2004 Apr; 3(4):360-4. PubMed ID: 15060531 [No Abstract] [Full Text] [Related]
18. [Pharmaceutical industry and clinical drug research]. Huttunen MO Duodecim; 2000; 116(24):2813-5. PubMed ID: 12077886 [No Abstract] [Full Text] [Related]
19. [Dishonesty in clinical trials is expensive for the society 2]. Lund BA; Nordby G Ugeskr Laeger; 2003 Jun; 165(26):2672. PubMed ID: 12886556 [No Abstract] [Full Text] [Related]
20. [Dishonesty in clinical trials is expensive for the society 3]. Waldorff S Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557 [No Abstract] [Full Text] [Related] [Next] [New Search]